325 related articles for article (PubMed ID: 38378607)
1. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
[TBL] [Abstract][Full Text] [Related]
2. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
[TBL] [Abstract][Full Text] [Related]
3. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.
Tian Y; Cai X; Zhou Y; Jin A; Wang S; Yang Y; Mei L; Jing J; Li S; Meng X; Wei T; Liu T; Wang Y; Pan Y; Wang Y
Stroke Vasc Neurol; 2023 Oct; 8(5):413-423. PubMed ID: 37045543
[TBL] [Abstract][Full Text] [Related]
4. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
[TBL] [Abstract][Full Text] [Related]
5. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
[TBL] [Abstract][Full Text] [Related]
6. Glymphatic Dysfunction Mediates the Influence of White Matter Hyperintensities on Episodic Memory in Cerebral Small Vessel Disease.
Ke Z; Mo Y; Li J; Yang D; Huang L; Yang Z; Qin R; Mao C; Lv W; Huang Y; Hu Z; Zhang B; Xu Y
Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552071
[TBL] [Abstract][Full Text] [Related]
7. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
Kamagata K; Andica C; Takabayashi K; Saito Y; Taoka T; Nozaki H; Kikuta J; Fujita S; Hagiwara A; Kamiya K; Wada A; Akashi T; Sano K; Nishizawa M; Hori M; Naganawa S; Aoki S;
Neurology; 2022 Dec; 99(24):e2648-e2660. PubMed ID: 36123122
[TBL] [Abstract][Full Text] [Related]
8. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
Hong H; Tozer DJ; Markus HS
Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
[TBL] [Abstract][Full Text] [Related]
10. PET/MRI multimodality imaging to evaluate changes in glymphatic system function and biomarkers of Alzheimer's disease.
Okazawa H; Nogami M; Ishida S; Makino A; Mori T; Kiyono Y; Ikawa M
Sci Rep; 2024 May; 14(1):12310. PubMed ID: 38811627
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.
Liang T; Chang F; Huang Z; Peng D; Zhou X; Liu W
Br J Radiol; 2023 Jun; 96(1146):20220315. PubMed ID: 37066824
[TBL] [Abstract][Full Text] [Related]
12. Glymphatic dysfunction mediates the influence of choroid plexus enlargement on information processing speed in patients with white matter hyperintensities.
Xu Y; Wang M; Li X; Lu T; Wang Y; Zhang X; Wang Z; Yan F
Cereb Cortex; 2024 Jun; 34(6):. PubMed ID: 38912605
[TBL] [Abstract][Full Text] [Related]
13. Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
Ota M; Sato N; Nakaya M; Shigemoto Y; Kimura Y; Chiba E; Yokoi Y; Tsukamoto T; Matsuda H
J Alzheimers Dis; 2022; 90(1):295-303. PubMed ID: 36120782
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Positivity in the Alzheimer/Subcortical-Vascular Spectrum.
Kang SH; Kim ME; Jang H; Kwon H; Lee H; Kim HJ; Seo SW; Na DL
Neurology; 2021 Apr; 96(17):e2201-e2211. PubMed ID: 33722997
[TBL] [Abstract][Full Text] [Related]
15. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
[TBL] [Abstract][Full Text] [Related]
16. Resting-state fMRI network efficiency as a mediator in the relationship between the glymphatic system and cognitive function in obstructive sleep apnea hypopnea syndrome: Insights from a DTI-ALPS investigation.
Xiong Z; Bai M; Wang Z; Wang R; Tian C; Wang L; Nie L; Zeng X
Sleep Med; 2024 Jul; 119():250-257. PubMed ID: 38704873
[TBL] [Abstract][Full Text] [Related]
17. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
18. Perivascular Spaces, Diffusivity Along Perivascular Spaces, and Free Water in Cerebral Small Vessel Disease.
Li H; Jacob MA; Cai M; Kessels RPC; Norris DG; Duering M; De Leeuw FE; Tuladhar AM
Neurology; 2024 May; 102(9):e209306. PubMed ID: 38626373
[TBL] [Abstract][Full Text] [Related]
19. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease.
Tang J; Zhang M; Liu N; Xue Y; Ren X; Huang Q; Shi L; Fu J
Front Aging Neurosci; 2022; 14():916633. PubMed ID: 35813943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
